tiprankstipranks

Dirk Thye Insider Profile

11 Followers
Dirk Thye, CMO at Cidara Therapeutics, holds 843.94K shares in Quince Therapeutics (Ticker: QNCX), holds 101.44K shares in Cidara Therapeutics (Ticker: CDTX). Most recently, Dirk Thye Bought ― shares of Quince Therapeutics on Sep 03, 2024 for an estimated value of 107.38K.
tipranks
Dirk Thye

Dirk Thye
Cidara Therapeutics (CDTX)
CMO

Ranked #26,148 out of 100,202 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

+23.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
61.06%
38.94%
A breakdown of Dirk Thye's holdings

Insider Roles

Cidara Therapeutics
(CDTX)
CMO
Quince Therapeutics
(QNCX)
CEO AND CHIEF MEDICAL OFFICER, Director
Roles that Dirk Thye holds in companies

Most Profitable Insider Trade

Stock:
Quince Therapeutics
(QNCX)
Rating:Informative Buy
Date:Sep 03, 2024 - Today
Return:+156.80%
The most profitable trade made by Dirk Thye

Dirk Thye's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cidara Therapeutics
Apr 14, 2015
CMO
Uninformative Buy
$2.36M
Quince Therapeutics
Sep 03, 2024
CEO AND CHIEF MEDICAL OFFICER, Director
Informative Buy
107.38K
$1.50M
List of latest transactions for each holding click on a transaction to see Dirk Thye's performance on stock

Dirk Thye insider profile FAQ

What is the percentage of profitable transactions made by Dirk Thye?
The percentage of profitable transactions made by Dirk Thye is 33%.
    What is the average return per transaction made by Dirk Thye?
    The average return per transaction made by Dirk Thye is 23.50%.
      What stocks does Dirk Thye hold?
      Dirk Thye holds: CDTX, QNCX stocks.
        What was Dirk Thye’s latest transaction?
        Dirk Thye latest transaction was an Informative Buy of $107.38K.
          What was Dirk Thye's most profitable transaction?
          Dirk Thye’s most profitable transaction was an Informative Buy of QNCX stock on September 3, 2024. The return on the trade was 156.80%.
            What is Dirk Thye's role in Cidara Therapeutics?
            Dirk Thye's role in Cidara Therapeutics is CMO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.